DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2021年6月08日 (火) 午後 7:00 - 2021年6月11日 (金) 午前 12:00

(Central Europe Standard Time)

4051 Basel, Switzerland

Future of Evidence and Smart Health Conference

Leveraging RWE to advance healthcare decision-making.

Session 10: What might the future of evidence generation and use look like?

Session Chair(s)

Thomas  Brookland, MSC

Thomas Brookland, MSC

Regulatory Science and Policy Lead

F. Hoffmann-La Roche Ltd, Switzerland

Increasing interest and excitement in the potential of health data and evidence within the healthcare community has been triggered by a number of developments, including the greater availability and quality of electronic healthcare information, the emergence of tools for advanced analysis of large data volumes (greater computing power, data handling and analysis techniques) and the ability to link data from multiple sources.

There are a multitude of European initiatives and projects ongoing in this data and evidence generation space, a number of which are being driven by the European Institutions and Regulatory bodies. However, the scope and objectives of these projects often seem to be framed within the next 3 – 5 years, with numerous goals citing 2025 as a target date.

This final session of the workshop will take a look at data and evidence generation a little further into the future and ask what might this space look like in the next 10 – 15 years time and what opportunities, challenges and policy implications may come with this that we should already be thinking about now.

Speaker(s)

Alison  Cave, PHD

Panel Discussion and Q&A

Alison Cave, PHD

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Chief Safety Officer

Cécile Mathilde Ollivier, MS

Contributing Panelist

Cécile Mathilde Ollivier, MS

Critical Path Institute, Netherlands

Vice President, Global Affairs - Managing Director, Europe

Irene  Nunes, PHD

Contributing Panelist

Irene Nunes, PHD

Flatiron Health, United States

VP, Head of Regulatory Affairs

Frank  Petavy, MS

Contributing Panelist

Frank Petavy, MS

European Medicines Agency, Netherlands

Head of Methodology

Jesper  Kjær, MS

Contributing Panelist

Jesper Kjær, MS

Danish Medicines Agency DKMA, Denmark

Director of DKMA Data Analytics Centre

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。